Aventiv Research (Now Centricity Research)

Aventiv Research (Now Centricity Research) Analysis

Aventiv Research, now known as Centricity Research, is a biotechnology startup established in 2007, operating in the United States. Led by Dr. Samir Arora, the company focuses on conducting phase 1-4 pharmaceutical, device, and diagnostic clinical trials across multiple therapeutic areas. With over 450 clinical trials and collaborations with 55 pharmaceutical sponsors, Aventiv Research has contributed to the approval of 16 drugs by the FDA.

The company has a dedicated team of principal and sub-investigators, research coordinators, recruitment coordinators, and data specialists, all with extensive experience in the field of medical research. Aventiv Research emphasizes its commitment to quality assurance, utilizing CRIO, a paperless platform, to ensure data accuracy, streamline regulatory processes, and expedite timelines.

Furthermore, Aventiv Research has established partnerships with physicians and their offices, with many physicians serving as partners in their studies. The company also offers consulting services for clinical trial setup, project management, and improvement, leveraging its team's over 25 years of combined experience in medical research.

With a solid track record of compliance, recruitment, and high-quality work, Aventiv Research, now rebranded as Centricity Research, presents an attractive opportunity for potential venture capital investment in the biotechnology sector.